Metabolomic Signature of Endometrial Cancer
- 2 January 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 17 (2), 804-812
- https://doi.org/10.1021/acs.jproteome.7b00503
Abstract
Endometrial cancer (EC) is the most common cancer of the female reproductive tract in developed Countries. At the moment, no effective screening system is available. Here, we evaluate the diagnostic performance of a serum metabolomic signature. Two enrollments were carried out: one constituted of 168 subjects: 88 with EC and 80 healthy women, was used for building the classification models. The second (used to establish the performance of the classification algorithm) was constituted of 120 subjects: 30 with EC, 30 with ovarian cancer, 10 with benign endometrial disease and 50 healthy controls. Two ensemble models were built, one with all EC vs. controls (Model I) and one in which EC patients were aggregated according to their histotype (Model II). Serum metabolomic analysis was conducted via gas chromatography-mass spectrometry, while classification was done by an ensemble learning machine. Accuracy ranged from 62% to 99% for the Model I and from 67% to 100% for the Model II. Ensemble model showed an accuracy of 100% both for Model I and II. The most important metabolites in class separation were: lactic acid, progesterone, homocysteine, 3-hydroxybutyrate, linoleic acid, stearic acid, myristic acid, threonine, and valine. The serum metabolomics signature of endometrial cancer patients is peculiar because it differs from that of healthy controls and from that of benign endometrial disease and from other gynecological cancers (such as ovarian cancer).Keywords
Funding Information
- Universit? degli Studi di Salerno
This publication has 35 references indexed in Scilit:
- Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression dataBioinformatics, 2011
- Cancer statistics, 2011CA: A Cancer Journal for Clinicians, 2011
- The Human Serum MetabolomePLOS ONE, 2011
- Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopyChemical Society Reviews, 2011
- Estimates of cancer incidence and mortality in Europe in 2008European Journal of Cancer, 2010
- Long-term survival of endometrioid endometrial cancer patientsVideosurgery and Other Miniinvasive Techniques, 2010
- Mathematical Modeling of Folate Metabolism: Predicted Effects of Genetic Polymorphisms on Mechanisms and Biomarkers Relevant to CarcinogenesisCancer Epidemiology, Biomarkers & Prevention, 2008
- Inhibitory effect of tumor cell–derived lactic acid on human T cellsBlood, 2007
- Biomarkers of dietary fatty acid intake and the risk of breast cancer: A meta‐analysisInternational Journal of Cancer, 2004
- THE METABOLISM OF TUMORS IN THE BODYThe Journal of general physiology, 1927